Basal ganglia hyperperfusion in a patient with systemic lupus erythematosus-related parkinsonism.
Department of Neurology, College of Medicine, Ajou University, Suwon, South Korea. phisland@chol.net
Phil Hyu
PH
Lee
Uk Shik
US
Joo
Oh Young
OY
Bang
Chang Hee
CH
Seo
D000328:Adult; D000978:Antiparkinson Agents / Q000627:therapeutic use; D001479:Basal Ganglia / Q000098:blood supply* / Q000000981:diagnostic imaging; D003693:Delirium / Q000209:etiology; D004830:Epilepsy, Tonic-Clonic / Q000209:etiology; D005260:Female; D006212:Hallucinations / Q000209:etiology; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007980:Levodopa / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy / Q000628:therapy; D010302:Parkinson Disease, Secondary / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology*; D011239:Prednisolone / Q000627:therapeutic use; D015899:Tomography, Emission-Computed, Single-Photon
D000978:Antiparkinson Agents; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D007980:Levodopa; D011239:Prednisolone